Achieving enterprise-wide quality requires more than just compliance—it demands a culture of continuous improvement. The Voluntary Improvement Program (VIP), developed by industry for industry in collaboration with MDIC, ISACA, and the FDA, is transforming how manufacturers enhance speed to market, reduce risk, and improve patient outcomes.
With a data-driven, third-party appraisal approach tailored to companies of all sizes, VIP provides actionable insights that drive operational excellence. Organizations that participate see tangible benefits, including improved key performance metrics, higher renewal rates, and greater overall satisfaction.
Discover how VIP can help your company stay ahead by fostering innovation, ensuring product consistency, and strengthening your quality systems beyond regulatory requirements.
This studio session explores how a quality-first mindset can drive success across an organization, from product development and operations to supply chain and manufacturing. Key topics include leveraging risk management to focus on high-priority areas, balancing speed to market with cost and quality considerations, and creating robust feedback loops to adapt and evolve processes. The discussion also highlights the importance of fostering a culture of quality through communication, accountability, and integrated performance objectives.
Hosted by Joe Sapiente, head of MDIC’s Science and Technology Group, the session features insights from Al Crouse, Head of QA/RA at CVRx, and George Serafin, CEO of NanoDX, who bring their extensive expertise to this engaging and practical conversation. A must-watch for MedTech leaders committed to operational excellence and innovation.
In this studio conversation, Joseph Sapiente, MDIC’s Senior Vice President of Science and Technology, discusses the critical role of quality assurance in shaping regulatory and clinical strategies. Joined by Al Crouse, Head of Quality at CVRx, and George Serafin, CEO of NanoDX, the panel explores essential topics including product classification, preclinical and clinical strategies, and the growing role of simulation and modeling in development. They also highlight the importance of risk management and enterprise-wide approaches to ensuring data integrity, biocompatibility, and cybersecurity in clinical trials. Learn how QA strategies can align with regulatory requirements and drive success from development to market. A must-watch for MedTech professionals striving to integrate quality into every stage of the product lifecycle.
This interview hosted by Joseph Sapiente, MDIC’s Senior Vice President of Science and Technology, explores how quality assurance (QA) can drive competitive advantage in the medical device industry. Featuring expert perspectives from Al Crouse, Vice President of Quality Assurance and Regulatory Affairs at CVRx, and George Serafin, CEO of NanoDX, the discussion covers essential topics such as the distinction between quality and compliance, building a culture of quality in early-stage companies, and linking quality outcomes to business success. Learn how early investment in quality, post-market surveillance, and enterprise-wide approaches can optimize regulatory and clinical strategies while aligning with business goals. A must-watch for leaders aiming to elevate quality practices and impact the healthcare ecosystem.
The MDIC Excellence in Quality Summit is a unique opportunity to learn adoptable cutting-edge practices to maximize the impact of investing in quality across your total product lifecycle. Hear from participants about their experience on the Boston water front and key takeaways they are bringing back to their work. The Summit provides opportunities to network with peers from companies at all phases of development, workshop personal use cases to bring back real solutions, and discover the empowerment of engaging with the Case for Quality Collaborative Community.
